Treatment of multiple sclerosis patients after 24 Natalizumab doses: a prospective observational study: the TY-STOP

Research output: Contribution to conferenceOther

Original languageEnglish
Pages445-445
Number of pages1
Publication statusPublished - 2014

Cite this